Immunization with meningococcal membrane-bound lipooligosaccharide accelerates granulocyte recovery and enhances lymphocyte proliferation in myelosuppressed mice

Pathobiology

Volumn 65, Issue 1, 1997, Pages 26-38

  Quakyi, Emmanuel K ^a   Carter, Patricia H ^a   Tsai, Chao Ming ^a   Marti, Gerald E ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cyclophosphamide; Flow cytometry; Granulocytes; Interferon ; Interleukin 1 ; Interleukin 3; Interleukin 6; Lipooligosaccharide; Meningococcus; Myelosuppression; Septic shock; White blood cell lysis

Indexed keywords

CELL SURFACE MARKER; CYCLOPHOSPHAMIDE; GALACTOSAMINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MENINGOCOCCUS VACCINE; OLIGOSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW SUPPRESSION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DEATH; GRANULOCYTE; IMMUNIZATION; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MEMBRANE VESICLE; MOUSE; NEISSERIA MENINGITIDIS; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYCLOPHOSPHAMIDE; CYTOKINES; FEMALE; GALACTOSAMINE; GRANULOCYTES; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-3; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; NEISSERIA MENINGITIDIS; SHOCK, SEPTIC; SPLEEN;

ANIMALIA; BACTERIA (MICROORGANISMS); MENINGOCOCCUS; NEISSERIA MENINGITIDIS; OAT MOSAIC VIRUS;

EID: 0030918432     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164100     Document Type: Article

References (49)

1. Morrison DC. Silverstein R. Bright SW, Chen TY. Flebbe LM. Lei MG: Monoclonal antibody to mouse lipopolysaccharide receptor protects mice against the lethal elTects of endotoxin. J Infect Dis 1990;62:1062-1068.
2. Morrison DC. Ryan JL: Endotoxin and disease mechanisms. Annu Rev Med 1987:38:417-432.
3. Tsai CM. Frasch CE. Rivera E. Höchstem HD: Measurement of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage. J Biol Stand 1989:17:249-258.
4. Bjune G. Hoiby EA. Gronnesby JK. Arnesen O. Fredriksen JH. Halstensen A. et al: Effect of outer membrane vesicle vaccine against scro group B meningococcal disease in Norway. Lancet 1991:338:1093-1096.
5. De Moraes JC. Perkins BA. Camargo MCC. Hidalgo NTR. Barbosa HA. Sacchi CT. ct al: Protective efficacy of a scrogroup B meningococcal vaccine in Sao Paulo. Brazil. Lancet 1992;340:1074-1078.
6. Frasch CE. Coctzce G. Zahradnik JM, Feldman HA. Koomhof HJ: Development and evaluation of scrogroup B serotype 2 protein vaccines: Report of a serogroup B field trial. Med Trop 1983:43:177-183.
7. Norcnha CP: Avaliacao de eficacia da vaeina anti-mcningococicia BC no Rio de Janeiro: un estuilo caso-controle. thesis. Rio de Janeiro. 1993,1-232.
8. Sierra VG. Campa C. Garcia L, et al: Efficacy evaluation of the Cuban vaccine VA-MEN-GOC-BC against disease caused by sero-group B Neisseria meningitidis, in Achtman M (ed): Neisseria. Berlin, dc Gruyter, 1991. pp 129-134.
9. Osmond DCI, Park YU: B lymphocyte progenitors in murine bone marrow. Int Rev Immunol 1987:2:241.
10. Cline MJ. Ciolde DW: Cellular interaction in hematopoicsis. Nature 1979:277:177.
11. Athens JW. Haab OP. Raabb SO, Maucr AM. Ashenbrucker HA. Cartwright GE. Wimrobe MM: Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 1961:40:989-995.
12. Bodline DM. Orlic D. Birkett NC. Seidel NE. Zsebo KM: Stem cell factor increase colony-forming unit-spleen number in vitro in synergy with interleukin 6. and in vivo SI/SI*1 mice as a single factor. Blood 1992:79:913.
13. Ikebuchi K. Wong GG. Clark SC, Ihle JN. Hirai Y. Ogawa M: Interleukin-6 enhancement of interleukin-3-dependenl proliferation of multipotcntial hemopoietic progenitors. Proc Nall Acad Sci LISA 1987:84:9035-9039.
14. Stanley ER. Bartocci A. Patinkin D. Roscndaal M. Bradley TR: Regulation of very primitive, multipotent. hemopoietic cells by hemopoie-tin-1. Cell 1986:45:667.
15. Zsebo KM. Wvpych I. Yuschenkuff VN. Lu H. Hunt P. Dukes PP. Langley KE: Effects of hematopoietin-l and interleukin-1 activities on early hematopoietic cells of the bone marrow. Blood 1988:71:962.
16. Ikebuchi K. Ihle JN, Hirai Y, Wong GG, Clark SC. Ogawa M: Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood 1988:72: 2007.
17. Muench MO. Schneider JG, Moore MAS: Interactions among colony-stimulating factors. IL-P. IL-6 and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Heñíalo! 1992:20:339.
18. Brugger W, Mocklint W, Heinfold S. Bcrcnson RJ. Mertelsmann R. Kanz I.,: Ex vivo expansion of enriched peripheral blood CD34* progenitor cells by stem cell factor, interleukin-Ip, IL-6, IL-3, intcrferon-y and erythropoietin. Blood 1993:81:2579-2584.
19. Snocck IIW. Van Bockstacle DR. Nys G. Len-jou M. Lardón F. Haencn L, Rodrigus I. Peetcrman ME. Bcrncmann ZN: lnterferon-y selectively inhibits very primitive CD34' CD38 and not more mature CD34* CD38* human hematopoietic progenitor cells. J Exp Med 1994:180:1177-1182.
20. Julius MH. Simpson E. Herzenberg LA: A rapid method for isolation of functional thymus derived murine lymphocytes. Eur J Immunol 1973:3:645.
21. Mechanic RC. Frci F. Landy M. Smith WW: Quantitative studies of human leukocytic and febrile responses to single and repeated doses of purified bacterial endotoxin. J Clin Invest 1962:41:162-172.
22. Adler SS. Kuznctsky RD: Effeetsofchemotherapeutic agents in hematopoietic stromal tissue. 1. Effect of cyclophosphamide and bleomycin on hemapoiesis in subcutaneous femur implants. Exp Hematol 1984:12:153-161.
23. Botnick LE. Hannon EC. Vigneulle R. Heilman S: Differential effect of cytotoxic agents on hematopoietic progenitors. Cancer Res 1981: 41:2338-2342.
24. Dcwys WD. Goldin A. Mantel N: Hematopoietic recovery after large doses of cyclophosphamide: Correlation of proliferative state with sensitivity. Cancer Res 1970:30:1692-1697.
25. Mueller-Sieburg CE. Whitlock CA, Weissman IL: Isolation of two early B lymphocyte progenitors from mouse marrow, a committed prc-B cell and a clonogenic Thv-1 to hematopoietic stem cell. Cell 1986:44:653.
26. Stork L. Barczuk L, Kissinger M. Robinson W: Interleukin-1 accelerates murine granulocyte recovery following treatment with cyclophosphamide. Blood 1989;73:938-944.
27. Benjamin WR. Tares NS. Hayes TJ. Becker JM. Anderson TD: Regulation of hemopoiesis in myelosuppressed mice by human recombinant IL-lu. J Immunol 1989:142:792-799.
28. Castclli MR. Black PL. Schneider M. Pennington R. Abe F. Talmadge JE: Protective, restorative and therapeutic properties of recombinant human IL-I in rodent models. J Immunol 1988;140:3830-3837.
29. Metcalf D: The granulocyte-macrophage colony-stimulating factors. Cell 1985:43:5-6.
30. Moore MAS. Stolfi RL, Martin DS: Hematologic effects of IL-1 beta, G-CSF and GM-CSF in tumor bearing mice treated with 5-fluorou-racil., J Natl Cancer Inst 1990:82:1031-1037.
31. Hattori K. Shimizu K. Takahasi M. Tatnura M, Oheda M. Ohsawa N. Ono M: Quantitative in vivo assay of human granulocyte colony-stimulating factor using cvclophosphamide-in-duccd neutropenic mice. Blood 1990:75:1228-1233.
32. Johnson CS, Keckler DJ, Topper ML Braunschweig PG, Furmanski P: In vivo hematopoietic effeetsof recombinant interleukin-lu in mice: Stimulation of granulocytic, monocytic. mcgakaryotic. and early ervthroid progenitors. suppression of late-stage erythropoiesis, and reversal of ervthroid suppression with erythropoietin. Blood 1980:73:678-683.
33. Bonta IL, Ben-Elfrain S: Involvement of inflammatory mediators in macrophage antitumor activity. J Leukocyte Biol 1993:54:613.
34. Kishimoto T: The biology of mtcrlcukin-6. Blood 1989:74:1-10.
35. Rola-Pleszczynski M. Stakora J: Leukotriene Bienhances interleukin 6 (IL.,-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: Transcriptional and posttranscriptiona! mechanisms. Blood 1992: 80:1004.
36. Ryffcl B. Mihatsch MJ. Woerby G: Pathology induced by interleukin-6. Int Rev Exp Pathol 1993:34:79.
37. Wolvckamp MC. Marquet RL: lnterleukin-6: Historical background, genetics and biological significance. Immunol 1-ctl 1990:24:1.
38. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 1993:81:2844.
39. Gamick MB. O'Reilly RH: Clinical promise of new hematopoietic growth factors M-CSF. IL-3 and IL-6. Hematol Oncol Clin North Am 1989; 3:495.
40. Slordal I. Warren DJ. Moore MAS: Protective effects of tumor necrosis factor on murine hematopoicsis during cycle-specific cytotoxic chemotherapy. Cancer Res 1990:50:4216-4220
41. Shiohara M, Koike K. Nakahata T: Synergism of interferon-y and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. Blood I993;81: 1435-1441.
42. Shiohara M. Koike K. Nakahata T. Komiyama A: Hematopoietic progenitors and synergism of interfcron-y and stem cell factor. L., cuk Lymphoma 1994:14:203-211.
43. Okaca S. Nakauchi H. Nagayoshi K. Nakamura M. Miura Y. Suda T: Synergistic effects of IL-3 and 11.,-6 on highly enriched murine henia-poictic progenitors. Exp Hematol 1992:20: 546-551.
44. Okar OA. Suzuki C. Takatsuki F: In vitro expansion of the murine pluripotent hema-poietic stem cell population in response to interleukin 3 and interleukin 6. Transplantation 1989:48:495-498.
45. Zilnik RJ. Zhen T. Elias JA: cAMP inhibition of interleukin-1 induced interleukin-6 production by human lung fibroblasts. Am J Physiol 1993:264:1253.
46. Dinarrello CA: Biology of interleukin-1. FA-SEBJ 1988:2:108-115.
47. Maraskovsky E. Chen WF. Shortman K: IL-2 and IFN-gamma are two necessary lympho-kines in the development of cytolytic T-cclls. J Immunol 1989;143:1210-1214.
48. Trinchieri G. Peerussia B. Immune interferon: A plciolropic lymphokincwith multiple effects. Immunol Today 1985,6:131-149.
49. Fey GH. Hocke GM. Wilson DR, Rippergcr JA. Juan TSC. Cui MZ. Darlington GJ: Cytokines and the acute phase response of the liver, in Arias IM. Boyer JL. Fausto N. Jakobv WB. Schactcr DA. Shafritz DA (eds): The Liver Biology and Pathobiology. New York. Raven. 1994. pp 113-143.